Inovio's INO-3112: A Potential Game-Changer for RRP episode artwork

EPISODE · May 13, 2026 · 2 MIN

Inovio's INO-3112: A Potential Game-Changer for RRP

from The Daily News Now! Business

Inovios Q1 2026 update: INO-3112s FDA approval for RRP, a mid-cycle review with no major issues, and a potential informal meeting for accelerated approval. Docs and patients back HPV-specific therapies, with a new statement from top RRP specialists. Inovio prepares for a self-managed U.S. launch, boosted by a $16M public offering, and has a strong pipeline with new collaborations and cash runway into 2027. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/200234d856df883a

NOW PLAYING

Inovio's INO-3112: A Potential Game-Changer for RRP

0:00 2:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 2 minutes long.

When was this The Daily News Now! Business episode published?

This episode was published on May 13, 2026.

What is this episode about?

Inovios Q1 2026 update: INO-3112s FDA approval for RRP, a mid-cycle review with no major issues, and a potential informal meeting for accelerated approval. Docs and patients back HPV-specific therapies, with a new statement from top RRP...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!